Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RZLT
#3285
Rezolute, Inc. Common Stock (NV)
3.5
2
USD
-1.95%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.95%
Monthly Change
+42.51%
6 month change
-59.91%
Year Change
+33.33%
Previous Close
3.5
9
Open
3.6
0
Bid
Ask
Low
3.5
0
High
3.6
0
Volume
117
Markets
US Stock Market
Healthcare
RZLT
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q1, 25
Q2, 25
Total assets
175.49 M
158.66 M
138.63 M
Total liabilities
13.36 M
11.5 M
10.63 M
Total equity
162.13 M
147.17 M
128 M
Total liabilities & shareholders' equities
175.49 M
158.66 M
138.63 M
Total debt
—
—
—
Net debt
—
—
—
News
Rezolute: Sell Rating Despite FDA Feedback From Type B Meeting For Ersodetug (NASDAQ:RZLT)
Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
Alger Small Cap Growth Fund Q4 2025 Portfolio Update
Jefferies reiterates Buy rating on Rezolute stock, maintains $4 target
Rezolute shares mixed results from Phase 3 trial for rare disease therapy
Leerink Partners reiterates Outperform rating on XOMA stock at $45 target
RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know
Rezolute CFO Evans buys shares worth $79,577
Elam Nevan C, Rezolute CEO, buys $50k in RZLT shares
Rezolute’s CCO Karnawat buys $19,598 in shares
Down 81.8% in 4 Weeks, Here's Why Rezolute (RZLT) Looks Ripe for a Turnaround
Micron, Nike Set To Report Earnings Next Week